Clinical Trial Results: A Study to Learn How Gadoquatrane Moves Into, Through, and Out of the Body and How Safe it is in Children (From Birth to <18 Years), Who Will Undergo a Contrast Enhanced MRI (Quanti Pediatric) [Phase 3]

View source ↗

Summary

Phase 3 pediatric study assessing safety and pharmacokinetics of gadoquatrane for contrast-enhanced MRI in children from birth to under 18 years, with completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-enhanced Magnetic Resonance Imaging in Children

Drugs mentioned

• Gadoquatrane (gadoquatrane)

Snippet

Sponsor: Bayer | Conditions: Contrast Enhancement in Magnetic Resonance Imaging, Children | Phase 3 | Status: COMPLETED | Results posted: 2026-07-17